3 recruiting, 2 completed, 1 not yet recruiting, 1 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Renal Diseases: new trials by email Literature Review of Renal Diseases trials Research Report on Renal Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Machine Learning and Artificial Intelligence Algorithms to Optimize the Performance and Delivery of Acute Dialysis intermittent OR continuous renal replacement therapies - Renal Dialysis, Renal Replacement Therapy | Not yet recruiting | University of Alberta | 7500 | 2026-10-01 | 2026-09-24 | |
| A Dietitian-Driven Unified Nutritional Care Model (ADDUCE) Dietitian-driven nutritional care model, Current practice nutritional care - Hospitalized Adult Patients, Inpatient Internal Medicine Patients | Not applicable | Recruiting | Gødstrup Hospital | 216 | 2026-08-11 | 2026-08-31 |
| New Advanced Vascular Imaging Ultrasound Protocols US acquisitions - Renal Diseases, Cerebral Disorder | Recruiting | Mario Negri Institute for Pharmacological Research | 60 | 2025-05-09 | 2025-09-05 | |
| Multidisciplinary Dissection of Renal and Metabolic Effects of Glyfozines on Elderly Patients: From Molecular Aspects to Clinical Indications Elderly Patients (>65 Years), Diabetes (DM) | Recruiting | Chiara Lanzani | 300 | 2025-02-14 | 2025-08-13 | |
| Trends of Renal Biopsy in Pediatric Patients at Tanta University Hospital for 10 Years From 2012 to 2022. renal biopsy - Renal Diseases | Unknown | Tanta University | 1000 | 2023-11-28 | 2024-08-06 | |
| PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients epoetin alfa - Anemia, Renal Diseases | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 430 | 2007-07-01 | 2014-04-21 |
| A Study to Evaluate the Pharmacokinetics and Safety of Levofloxacin in Patients With Varying Degrees of Renal Function. Levofloxacin - Renal Diseases | Phase 1 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 59 | 2004-10-01 | 2011-06-08 |
Kidney Diseases (7) · Anemia (1) · Communicable Diseases (1) · Diabetes Mellitus (1) · Heart Diseases (1) · Hematologic Diseases (1) · Lung Diseases (1) · Renal Insufficiency, Chronic (1)
Female Urogenital Diseases (7) · Female Urogenital Diseases and Pregnancy Complications (7) · Male Urogenital Diseases (7) · Urogenital Diseases (7) · Urologic Diseases (7) · Disease Attributes (2) · Hemic and Lymphatic Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Cardiovascular Diseases (1) · Chronic Disease (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Hematologic Diseases (1) · Infections (1)
Epoetin Alfa (1) · Levofloxacin (1)
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2) · Chiara Lanzani (1) · Gødstrup Hospital (1) · Mario Negri Institute for Pharmacological Research (1) · Tanta University (1) · University of Alberta (1)
Italy (2) · Canada (1) · Denmark (1) · Egypt (1) · United States (1)
Giuseppe Remuzzi, M.D. (1) · Marianne Boll Kristensen, RD, PhD (1) · Oleksa G Rewa, MD MSc (1) · Sara Mabrouk Mohamed Elghoul, MD (1)